Yersinia Diagnostics Market Size, Share, Competitive Landscape and Trend Analysis Report, by Test types and, by Techniques : Global Opportunity Analysis and Industry Forecast, 2023-2032

Yersinia is a rod-shaped, gram positive bacterium in the Enterobacteriaceae family that causes enterocolitis, terminal iletis, mesenteric lymphadenitis, acute diarrhea and sepsis. The pathogen species of Yersinia include Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis. These species of Yersinia cause the Bubonic plague and gastroenteritis respectively. The symptoms of the diseases caused by these bacteria include gastroenteritis, vomiting, abdominal pain, low grade fever and diarrhea. The infection usually occurs in children. This infection affects men more often than women. 

The treatment includes administration of cephalosporins, fluoroquinolones, tetracyclines, trimethoprim-sulfamethoxasole (TMP-SMZ) and aminoglycosides. There are several diagnostic tests that are performed to detect the infections, such as stool culture, ELISA, radioimmunoassay, tube agglutination, CT scan, ultrasonography, colonoscopy etc. Several techniques such as PCR utilize monoclonal antibodies to identify the infections. As per the geographic analysis, North America holds the dominant share in the Yersinia diagnostics market due to the rising incidence of the infections. The Asia Pacific region is the fastest growing region due to the presence of untapped opportunities and high prevalence of infection in countries like India and Japan. 

Key benefits 

• An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
• Comprehensive analysis of the factors that drive and restrict the growth of the Yersinia diagnostics market is provided
• Key regulatory guidelines of various regions which impact the Yersinia diagnostics market are critically examined 
• Quantitative analysis of the current market and estimations are provided to showcase the financial caliber of the market
• Deep dive analysis of various regions provides insights that would enable companies to plan their business moves strategically
• Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the Yersinia diagnostics market     

  Yersinia Diagnostics Market Report Highlights

Aspects	Details
By Test types	Stool Culture ELISA Radioimmunoassay Tube Agglutination CT Scan Ultrasonography Colonoscopy
By Techniques	PCR DNA Probes Monoclonal Antibodies Immunoassay IT Others
By Geography	North America Asia Pacific Europe LAMEA
Key Market Players	Abbott Laboratories, Bio-Rad, Affymetrix Inc, Gen-probe

^*Terms and Conditions Apply